Gadoxetic acid (Gd-EOB-DTPA)-enhanced mri versus gadobenate dimeglumine (Gd-BOPTA)-enhanced MRI for preoperatively detecting hepatocellular carcinoma

An initial experience

Yulri Park, Seong Hyun Kim, Seung Hoon Kim, Yong Hwan Jeon, Jongmee Lee, Min Ju Kim, Dongil Choi, Won Jae Lee, Heejung Kim, Ji Hyun Koo, Hyo Keun Lim

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Objective: This study was designed to compare the diagnostic performance of gadoxetic acid-enhanced magnetic resonance imaging (MRI) with gadobenate dimeglumine-enhanced MRI for preoperatively detecting hepatocellular carcinoma (HCC). Materials and Methods: Eighteen consecutive patients (17 men and one woman, age range: 31-73 years) with 22 HCCs underwent examinations with gadoxetic acid enhanced MRI and gadobenate dimeglumine-enhanced MRI on a 3.0-Tesla unit. The diagnosis of HCC was established after surgical resection and pathological conformation. Three observers independently reviewed each MR image in a random order on a tumor-by-tumor basis. The diagnostic accuracy of these techniques for the detection of HCC was assessed by performing an alternative free-response receiver operating characteristic (ROC) analysis. The sensitivity and positive predictive values were evaluated. Results: The average value of the area under the ROC curve (Az) for gadoxetic acid enhanced MRI (0.887) was not significantly different from the Az (0.899) for gadobenate dimeglumine-enhanced MRI (p > 0.05). The overall sensitivities of gadoxetic acid enhanced MRI and gadobenate dimeglumine-enhanced MRI were 80% and 83%, respectively, with no significant difference (p > 0.05). The differences of the positive predictive values for the two contrast agents for each observer were not statistically significant (p > 0.05). Conclusion: The diagnostic performance of gadoxetic acid-enhanced MRI and gadobenate dimeglumine-enhanced MRI for preoperatively detecting HCC is quite similar.

Original languageEnglish
Pages (from-to)433-440
Number of pages8
JournalKorean Journal of Radiology
Volume11
Issue number4
DOIs
Publication statusPublished - 2010 Jul 1

Fingerprint

Hepatocellular Carcinoma
Magnetic Resonance Imaging
ROC Curve
gadolinium ethoxybenzyl DTPA
gadobenic acid
Contrast Media
Neoplasms

Keywords

  • Gadobenate dimeglumine-enhanced MRI
  • Gadoxetic acid-enhanced MRI
  • Hepatocellular carcinoma (HCC)

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Gadoxetic acid (Gd-EOB-DTPA)-enhanced mri versus gadobenate dimeglumine (Gd-BOPTA)-enhanced MRI for preoperatively detecting hepatocellular carcinoma : An initial experience. / Park, Yulri; Kim, Seong Hyun; Kim, Seung Hoon; Jeon, Yong Hwan; Lee, Jongmee; Kim, Min Ju; Choi, Dongil; Lee, Won Jae; Kim, Heejung; Koo, Ji Hyun; Lim, Hyo Keun.

In: Korean Journal of Radiology, Vol. 11, No. 4, 01.07.2010, p. 433-440.

Research output: Contribution to journalArticle

Park, Yulri ; Kim, Seong Hyun ; Kim, Seung Hoon ; Jeon, Yong Hwan ; Lee, Jongmee ; Kim, Min Ju ; Choi, Dongil ; Lee, Won Jae ; Kim, Heejung ; Koo, Ji Hyun ; Lim, Hyo Keun. / Gadoxetic acid (Gd-EOB-DTPA)-enhanced mri versus gadobenate dimeglumine (Gd-BOPTA)-enhanced MRI for preoperatively detecting hepatocellular carcinoma : An initial experience. In: Korean Journal of Radiology. 2010 ; Vol. 11, No. 4. pp. 433-440.
@article{90816c5037634a4290b705349834c9de,
title = "Gadoxetic acid (Gd-EOB-DTPA)-enhanced mri versus gadobenate dimeglumine (Gd-BOPTA)-enhanced MRI for preoperatively detecting hepatocellular carcinoma: An initial experience",
abstract = "Objective: This study was designed to compare the diagnostic performance of gadoxetic acid-enhanced magnetic resonance imaging (MRI) with gadobenate dimeglumine-enhanced MRI for preoperatively detecting hepatocellular carcinoma (HCC). Materials and Methods: Eighteen consecutive patients (17 men and one woman, age range: 31-73 years) with 22 HCCs underwent examinations with gadoxetic acid enhanced MRI and gadobenate dimeglumine-enhanced MRI on a 3.0-Tesla unit. The diagnosis of HCC was established after surgical resection and pathological conformation. Three observers independently reviewed each MR image in a random order on a tumor-by-tumor basis. The diagnostic accuracy of these techniques for the detection of HCC was assessed by performing an alternative free-response receiver operating characteristic (ROC) analysis. The sensitivity and positive predictive values were evaluated. Results: The average value of the area under the ROC curve (Az) for gadoxetic acid enhanced MRI (0.887) was not significantly different from the Az (0.899) for gadobenate dimeglumine-enhanced MRI (p > 0.05). The overall sensitivities of gadoxetic acid enhanced MRI and gadobenate dimeglumine-enhanced MRI were 80{\%} and 83{\%}, respectively, with no significant difference (p > 0.05). The differences of the positive predictive values for the two contrast agents for each observer were not statistically significant (p > 0.05). Conclusion: The diagnostic performance of gadoxetic acid-enhanced MRI and gadobenate dimeglumine-enhanced MRI for preoperatively detecting HCC is quite similar.",
keywords = "Gadobenate dimeglumine-enhanced MRI, Gadoxetic acid-enhanced MRI, Hepatocellular carcinoma (HCC)",
author = "Yulri Park and Kim, {Seong Hyun} and Kim, {Seung Hoon} and Jeon, {Yong Hwan} and Jongmee Lee and Kim, {Min Ju} and Dongil Choi and Lee, {Won Jae} and Heejung Kim and Koo, {Ji Hyun} and Lim, {Hyo Keun}",
year = "2010",
month = "7",
day = "1",
doi = "10.3348/kjr.2010.11.4.433",
language = "English",
volume = "11",
pages = "433--440",
journal = "Korean Journal of Radiology",
issn = "1229-6929",
publisher = "Korean Radiological Society",
number = "4",

}

TY - JOUR

T1 - Gadoxetic acid (Gd-EOB-DTPA)-enhanced mri versus gadobenate dimeglumine (Gd-BOPTA)-enhanced MRI for preoperatively detecting hepatocellular carcinoma

T2 - An initial experience

AU - Park, Yulri

AU - Kim, Seong Hyun

AU - Kim, Seung Hoon

AU - Jeon, Yong Hwan

AU - Lee, Jongmee

AU - Kim, Min Ju

AU - Choi, Dongil

AU - Lee, Won Jae

AU - Kim, Heejung

AU - Koo, Ji Hyun

AU - Lim, Hyo Keun

PY - 2010/7/1

Y1 - 2010/7/1

N2 - Objective: This study was designed to compare the diagnostic performance of gadoxetic acid-enhanced magnetic resonance imaging (MRI) with gadobenate dimeglumine-enhanced MRI for preoperatively detecting hepatocellular carcinoma (HCC). Materials and Methods: Eighteen consecutive patients (17 men and one woman, age range: 31-73 years) with 22 HCCs underwent examinations with gadoxetic acid enhanced MRI and gadobenate dimeglumine-enhanced MRI on a 3.0-Tesla unit. The diagnosis of HCC was established after surgical resection and pathological conformation. Three observers independently reviewed each MR image in a random order on a tumor-by-tumor basis. The diagnostic accuracy of these techniques for the detection of HCC was assessed by performing an alternative free-response receiver operating characteristic (ROC) analysis. The sensitivity and positive predictive values were evaluated. Results: The average value of the area under the ROC curve (Az) for gadoxetic acid enhanced MRI (0.887) was not significantly different from the Az (0.899) for gadobenate dimeglumine-enhanced MRI (p > 0.05). The overall sensitivities of gadoxetic acid enhanced MRI and gadobenate dimeglumine-enhanced MRI were 80% and 83%, respectively, with no significant difference (p > 0.05). The differences of the positive predictive values for the two contrast agents for each observer were not statistically significant (p > 0.05). Conclusion: The diagnostic performance of gadoxetic acid-enhanced MRI and gadobenate dimeglumine-enhanced MRI for preoperatively detecting HCC is quite similar.

AB - Objective: This study was designed to compare the diagnostic performance of gadoxetic acid-enhanced magnetic resonance imaging (MRI) with gadobenate dimeglumine-enhanced MRI for preoperatively detecting hepatocellular carcinoma (HCC). Materials and Methods: Eighteen consecutive patients (17 men and one woman, age range: 31-73 years) with 22 HCCs underwent examinations with gadoxetic acid enhanced MRI and gadobenate dimeglumine-enhanced MRI on a 3.0-Tesla unit. The diagnosis of HCC was established after surgical resection and pathological conformation. Three observers independently reviewed each MR image in a random order on a tumor-by-tumor basis. The diagnostic accuracy of these techniques for the detection of HCC was assessed by performing an alternative free-response receiver operating characteristic (ROC) analysis. The sensitivity and positive predictive values were evaluated. Results: The average value of the area under the ROC curve (Az) for gadoxetic acid enhanced MRI (0.887) was not significantly different from the Az (0.899) for gadobenate dimeglumine-enhanced MRI (p > 0.05). The overall sensitivities of gadoxetic acid enhanced MRI and gadobenate dimeglumine-enhanced MRI were 80% and 83%, respectively, with no significant difference (p > 0.05). The differences of the positive predictive values for the two contrast agents for each observer were not statistically significant (p > 0.05). Conclusion: The diagnostic performance of gadoxetic acid-enhanced MRI and gadobenate dimeglumine-enhanced MRI for preoperatively detecting HCC is quite similar.

KW - Gadobenate dimeglumine-enhanced MRI

KW - Gadoxetic acid-enhanced MRI

KW - Hepatocellular carcinoma (HCC)

UR - http://www.scopus.com/inward/record.url?scp=77954767195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954767195&partnerID=8YFLogxK

U2 - 10.3348/kjr.2010.11.4.433

DO - 10.3348/kjr.2010.11.4.433

M3 - Article

VL - 11

SP - 433

EP - 440

JO - Korean Journal of Radiology

JF - Korean Journal of Radiology

SN - 1229-6929

IS - 4

ER -